Interview: Tuberculosis Diagnostics at R-Biopharm
“Early and consistent tuberculosis detection to break infection chains and eliminate the disease worldwide” R-Biopharm has launched a new generation of diagnostics for the global [...]
Dear customers,
we have started to provide the documents for our products in an electronic format. These are the Instructions for Use (IFU), the Safety Data Sheets (SDS) and the Certificate of Analysis (CoA). For batches placed on the market after 01 January 2023, you can find our documents on the eIFU portal https://eifu.r-biopharm.com.
32nd Annual Meeting of the Society for Virology
ESCV 2022
R-Biopharm announces quality products distribution agreement with Microbix
Mississauga, Canada and Darmstadt, Germany, 15th May 2020 – R-Biopharm AG and Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator, announces the appointment of R-Biopharm [...]
Videos
Delayed food allergies
R-Biopharm AG receives FDA clearance for RIDA®GENE Norovirus GI/GII, a real time RT-PCR assay for the detection and differentiation of norovirus genogroup I (GI) and II (GII)
Immunoblot assays
Systems
R-Biopharm launches new generation of RIDA®UNITY
We are proud to present you today the new generation of the RIDA® UNITY system. RIDA®UNITY, now with 4 real time PCR cyclers, stands for efficiently generated accurate results in molecular [...]